Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, et al. Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (Lond). 2021;41(11):1183–94. https://doi.org/10.1002/cac2.12207.

Article  PubMed  Google Scholar 

Yen AM, Tsau HS, Fann JC, Chen SL, Chiu SY, Lee YC, et al. Population-based breast cancer screening with risk-based and universal mammography screening compared with clinical breast examination: a propensity score analysis of 1 429 890 Taiwanese women. JAMA Oncol. 2016;2(7):915–21. https://doi.org/10.1001/jamaoncol.2016.0447.

Article  PubMed  Google Scholar 

Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, et al. Benefits and harms of breast cancer screening: a systematic review. JAMA. 2015;314(15):1615–34. https://doi.org/10.1001/jama.2015.13183.

Article  CAS  PubMed  Google Scholar 

Leng J, Lei L, Lei SF, Zhu Z, Ocampo A, Gany F. Use of traditional Chinese herbal medicine concurrently with conventional cancer treatment among Chinese cancer patients. J Immigr Minor Health. 2020;22(6):1240–7. https://doi.org/10.1007/s10903-020-01017-2.

Article  PubMed  PubMed Central  Google Scholar 

Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008;269(2):199–225. https://doi.org/10.1016/j.canlet.2008.03.009.

Article  CAS  PubMed  Google Scholar 

Shankar S, Ganapathy S, Srivastava RK. Green tea polyphenols: biology and therapeutic implications in cancer. Front Biosci. 2007;12:4881–99. https://doi.org/10.2741/2435.

Article  CAS  PubMed  Google Scholar 

Wang W, Zhang X, Qin JJ, Voruganti S, Nag SA, Wang MH, et al. Natural product ginsenoside 25-OCH3-PPD inhibits breast cancer growth and metastasis through down-regulating MDM2. PLoS One. 2012;7(7):e41586. https://doi.org/10.1371/journal.pone.0041586.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rauf A, Imran M, Butt MS, Nadeem M, Peters DG, Mubarak MS. Resveratrol as an anti-cancer agent: A review. Crit Rev Food Sci Nutr. 2018;58(9):1428–47. https://doi.org/10.1080/10408398.2016.1263597.

Article  PubMed  Google Scholar 

Lai H, Singh NP. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett. 1995;91(1):41–6. https://doi.org/10.1016/0304-3835(94)03716-v.

Article  CAS  PubMed  Google Scholar 

Tillhon M, Guamán Ortiz LM, Lombardi P, Scovassi AI. Berberine: new perspectives for old remedies. Biochem Pharmacol. 2012;84(10):1260–7. https://doi.org/10.1016/j.bcp.2012.07.018.

Article  CAS  PubMed  Google Scholar 

Shan Y, Wu K, Wang W, Wang S, Lin N, Zhao R, et al. Sulforaphane down-regulates COX-2 expression by activating p38 and inhibiting NF-κB-DNA-binding activity in human bladder T24 cells. Int J Oncol. 2009;34(4):1129–34. https://doi.org/10.3892/ijo_00000240.

Article  CAS  PubMed  Google Scholar 

Nourmohammadi S, Aung TN, Cui J, Pei JV, De Ieso ML, Harata-Lee Y, et al. Effect of compound kushen injection, a natural compound mixture, and its identified chemical components on migration and invasion of colon, brain, and breast cancer cell lines. Front Oncol. 2019;9:314. https://doi.org/10.3389/fonc.2019.00314.

Article  PubMed  PubMed Central  Google Scholar 

Guerra-Martín MD, Tejedor-Bueno MS, Correa-Casado M. Effectiveness of complementary therapies in cancer patients: a systematic review. Int J Environ Res Public Health. 2021. https://doi.org/10.3390/ijerph18031017.

Article  PubMed  PubMed Central  Google Scholar 

Kim W, Lee WB, Lee JW, Min BI, Baek SK, Lee HS, Cho SH. Traditional herbal medicine as adjunctive therapy for breast cancer: A systematic review. Complement Ther Med. 2015;23(4):626–32. https://doi.org/10.1016/j.ctim.2015.03.011.

Article  PubMed  Google Scholar 

Cohen I, Tagliaferri M, Tripathy D. Traditional Chinese medicine in the treatment of breast cancer. Semin Oncol. 2002;29(6):563–74. https://doi.org/10.1053/sonc.2002.50005.

Article  PubMed  Google Scholar 

Feng RQ, Li DH, Liu XK, Zhao XH, Wen QE, Yang Y. Traditional Chinese medicine for breast cancer: a review. Breast Cancer (Dove Med Press). 2023;15:747–59. https://doi.org/10.2147/bctt.S429530.

Article  CAS  PubMed  Google Scholar 

Xiang Y, Guo Z, Zhu P, Chen J, Huang Y. Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science. Cancer Med. 2019;8(5):1958–75. https://doi.org/10.1002/cam4.2108.

Article  PubMed  PubMed Central  Google Scholar 

Ye L, Jia Y, Ji K, Sanders AJ, Xue K, Ji J, et al. Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis (Review). Oncol Lett. 2015;10(3):1240–50. https://doi.org/10.3892/ol.2015.3459.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manheimer E, Wieland S, Kimbrough E, Cheng K, Berman BM. Evidence from the Cochrane Collaboration for traditional Chinese medicine therapies. J Altern Complement Med. 2009;15(9):1001–14. https://doi.org/10.1089/acm.2008.0414.

Article  PubMed  PubMed Central  Google Scholar 

Park YH, Senkus-Konefka E, Im SA, Pentheroudakis G, Saji S, Gupta S, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS. SSO and TOS Ann Oncol. 2020;31(4):451–69. https://doi.org/10.1016/j.annonc.2020.01.008.

Article  CAS  PubMed  Google Scholar 

Im SA, Gennari A, Park YH, Kim JH, Jiang ZF, Gupta S, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer. ESMO Open. 2023;8(3):101541. https://doi.org/10.1016/j.esmoop.2023.101541.

Article  PubMed  PubMed Central  Google Scholar 

Zagouri F, Liakou P, Bartsch R, Peccatori FA, Tsigginou A, Dimitrakakis C, et al. Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal. Breast. 2015;24(4):513–23. https://doi.org/10.1016/j.breast.2015.02.031.

Article  PubMed  Google Scholar 

Chan K. Some aspects of toxic contaminants in herbal medicines. Chemosphere. 2003;52(9):1361–71. https://doi.org/10.1016/s0045-6535(03)00471-5.

Article  CAS  PubMed  Google Scholar 

Sikorskii A, Wyatt G, Victorson D, Faulkner G, Rahbar MH. Methodological issues in trials of complementary and alternative medicine interventions. Nurs Res. 2009;58(6):444–51. https://doi.org/10.1097/NNR.0b013e3181bf15fe.

Article  PubMed  PubMed Central  Google Scholar 

Carlson LE, Bao T, Balneaves LG. Methodology flaws and implications of a complementary medicine study. JAMA Oncol. 2019;5(3):432.

Article  PubMed  Google Scholar 

Hsing AW, Ioannidis JP. Nationwide population science: lessons from the Taiwan national health insurance research database. JAMA Intern Med. 2015;175(9):1527–9. https://doi.org/10.1001/jamainternmed.2015.3540.

Article  PubMed  Google Scholar 

Huang CW, Hwang IH, Lee YS, Hwang SJ, Ko SG, Chen FP, Jang BH. Utilization patterns of traditional medicine in Taiwan and South Korea by using national health insurance data in 2011. PLoS One. 2018;13(12):e0208569. https://doi.org/10.1371/journal.pone.0208569.

Article  PubMed  PubMed Central  Google Scholar 

Administration NHI: List of Traditional Chinese Medicine Drugs. https://www.nhi.gov.tw/ch/cp-14300-03585-2467-1.html Accessed 07/26/2024.

Huang CW, Hwang IH, Yun YH, Jang BH, Chen FP, Hwang SJ, Ko SG. Population-based comparison of traditional medicine use in adult patients with allergic rhinitis between South Korea and Taiwan. J Chin Med Assoc. 2018;81(8):708–13. https://doi.org/10.1016/j.jcma.2017.12.008.

Article  PubMed